Clinical Trial Update: p-AKT Expression on Clinical Outcomes in Malignant Lymphoma

View source ↗

Summary

This clinical trial update examines the relationship between p-AKT expression and clinical outcomes in malignant lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Lymphoma

Snippet

Sponsor: Samsung Medical Center | Conditions: Malignant Lymphoma, P13K-AKT Pathway Deregulation | Status: COMPLETED